ASX - By Stock
|
KZA |
Re:
Dr. Matt Dun - Treatment Strategies for Kids battling DIPG/DMG
|
|
monkeymagic1000
|
25 |
8.1K |
4 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
25
|
8.1K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Share Price
|
|
monkeymagic1000
|
791 |
218K |
1 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
791
|
218K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases final data from P2 paxalisib trial
|
|
monkeymagic1000
|
107 |
33K |
1 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
107
|
33K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases final data from P2 paxalisib trial
|
|
monkeymagic1000
|
107 |
33K |
1 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
107
|
33K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases final data from P2 paxalisib trial
|
|
monkeymagic1000
|
107 |
33K |
4 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
107
|
33K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases final data from P2 paxalisib trial
|
|
monkeymagic1000
|
107 |
33K |
2 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
107
|
33K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
News: KZA Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million - SEC Filing
|
|
monkeymagic1000
|
4 |
1.3K |
8 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
4
|
1.3K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
monkeymagic1000
|
559 |
156K |
10 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
559
|
156K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Annual Report to shareholders
|
|
monkeymagic1000
|
46 |
11K |
2 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
46
|
11K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
monkeymagic1000
|
2.0K |
622K |
3 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
2.0K
|
622K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Ceasing to be a substantial holder
|
|
monkeymagic1000
|
5 |
2.9K |
0 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
5
|
2.9K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Presentation
|
|
monkeymagic1000
|
66 |
18K |
11 |
24/04/21 |
24/04/21 |
ASX - By Stock
|
66
|
18K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
PI3K Drugs for Alzheimers
|
|
monkeymagic1000
|
73 |
24K |
2 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
73
|
24K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
PI3K Drugs for Alzheimers
|
|
monkeymagic1000
|
73 |
24K |
3 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
73
|
24K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
monkeymagic1000
|
69 |
19K |
14 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
69
|
19K
|
14
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia licenses paxalisib to Simcere in Greater China
|
|
monkeymagic1000
|
112 |
33K |
8 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
112
|
33K
|
8
|
|
ASX - By Stock
|
1AD |
Re:
Pitt Street Valuation
|
|
monkeymagic1000
|
80 |
25K |
2 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
80
|
25K
|
2
|
|
ASX - By Stock
|
KDY |
Re:
DW8 Growth
|
|
monkeymagic1000
|
16K |
5.1M |
2 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
16K
|
5.1M
|
2
|
|
ASX - By Stock
|
KDY |
Re:
DW8 Growth
|
|
monkeymagic1000
|
16K |
5.1M |
3 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
16K
|
5.1M
|
3
|
|
ASX - By Stock
|
KDY |
Re:
DW8 Growth
|
|
monkeymagic1000
|
16K |
5.1M |
7 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
16K
|
5.1M
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Share Price
|
|
monkeymagic1000
|
791 |
218K |
1 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
791
|
218K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
PI3K Drugs for Alzheimers
|
|
monkeymagic1000
|
73 |
24K |
16 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
73
|
24K
|
16
|
|
ASX - By Stock
|
KZA |
Re:
PI3K Drugs for Alzheimers
|
|
monkeymagic1000
|
73 |
24K |
4 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
73
|
24K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
PI3K Drugs for Alzheimers
|
|
monkeymagic1000
|
73 |
24K |
2 |
07/02/21 |
07/02/21 |
ASX - By Stock
|
73
|
24K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
PI3K Drugs for Alzheimers
|
|
monkeymagic1000
|
73 |
24K |
4 |
07/02/21 |
07/02/21 |
ASX - By Stock
|
73
|
24K
|
4
|
|
ASX - By Stock
|
KDY |
Re:
DW8 Growth
|
|
monkeymagic1000
|
16K |
5.1M |
8 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
16K
|
5.1M
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Share Price
|
|
monkeymagic1000
|
791 |
218K |
2 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
791
|
218K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Share Price
|
|
monkeymagic1000
|
791 |
218K |
9 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
791
|
218K
|
9
|
|
ASX - By Stock
|
KDY |
Re:
DW8 Growth
|
|
monkeymagic1000
|
16K |
5.1M |
9 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
16K
|
5.1M
|
9
|
|
ASX - By Stock
|
KDY |
Re:
Price targets for 24/12/21 (ONLY)
|
|
monkeymagic1000
|
260 |
118K |
5 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
260
|
118K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
San Antonio Breast Cancer Symposium 8 Dec
|
|
monkeymagic1000
|
114 |
30K |
7 |
13/12/20 |
13/12/20 |
ASX - By Stock
|
114
|
30K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
San Antonio Breast Cancer Symposium 8 Dec
|
|
monkeymagic1000
|
114 |
30K |
1 |
12/12/20 |
12/12/20 |
ASX - By Stock
|
114
|
30K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
San Antonio Breast Cancer Symposium 8 Dec
|
|
monkeymagic1000
|
114 |
30K |
1 |
12/12/20 |
12/12/20 |
ASX - By Stock
|
114
|
30K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases Cantrixil top line final data
|
|
monkeymagic1000
|
49 |
11K |
2 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
49
|
11K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases Cantrixil top line final data
|
|
monkeymagic1000
|
49 |
11K |
9 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
49
|
11K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia releases Cantrixil top line final data
|
|
monkeymagic1000
|
49 |
11K |
14 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
49
|
11K
|
14
|
|
ASX - By Stock
|
KZA |
Re:
San Antonio Breast Cancer Symposium 8 Dec
|
|
monkeymagic1000
|
114 |
30K |
0 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
114
|
30K
|
0
|
|
ASX - By Stock
|
KDY |
Re:
Ann: Company Update
|
|
monkeymagic1000
|
98 |
28K |
10 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
98
|
28K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Share Price
|
|
monkeymagic1000
|
791 |
218K |
0 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
791
|
218K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Interim Results of Phase 2 GBM Trial Released
|
|
monkeymagic1000
|
26 |
6.6K |
3 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
26
|
6.6K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Interim Results of Phase 2 GBM Trial Released
|
|
monkeymagic1000
|
26 |
6.6K |
5 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
26
|
6.6K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Interim Results of Phase 2 GBM Trial Released
|
|
monkeymagic1000
|
26 |
6.6K |
0 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
26
|
6.6K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Interim Results of Phase 2 GBM Trial Released
|
|
monkeymagic1000
|
26 |
6.6K |
1 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
26
|
6.6K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Interim Results of Phase 2 GBM Trial Released
|
|
monkeymagic1000
|
26 |
6.6K |
5 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
26
|
6.6K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Interim Results of Phase 2 GBM Trial Released
|
|
monkeymagic1000
|
26 |
6.6K |
1 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
26
|
6.6K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Interim Results of Phase 2 GBM Trial Released
|
|
monkeymagic1000
|
26 |
6.6K |
7 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
26
|
6.6K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Interim Results of Phase 2 GBM Trial Released
|
|
monkeymagic1000
|
26 |
6.6K |
10 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
26
|
6.6K
|
10
|
|
ASX - By Stock
|
KDY |
Re:
Ann: DW8 signs strategic acquisition of Wine Delivery Australia
|
|
monkeymagic1000
|
338 |
104K |
8 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
338
|
104K
|
8
|
|
ASX - By Stock
|
KDY |
Re:
Ann: DW8 signs strategic acquisition of Wine Delivery Australia
|
|
monkeymagic1000
|
338 |
104K |
1 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
338
|
104K
|
1
|
|
ASX - By Stock
|
KDY |
Re:
Ann: DW8 signs strategic acquisition of Wine Delivery Australia
|
|
monkeymagic1000
|
338 |
104K |
5 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
338
|
104K
|
5
|
|